Literature DB >> 28033681

High endothelial venules associated with T cell subsets in the inflamed gut of newly diagnosed inflammatory bowel disease patients.

C S Horjus Talabur Horje1, C Smids1, J W R Meijer2, M J Groenen1, M K Rijnders2, E G van Lochem3, P J Wahab1.   

Abstract

Naive and central memory T lymphocytes (TN and TCM ) can infiltrate the inflamed gut mucosa in inflammatory bowel disease (IBD) patients. Homing of these subsets to the gut might be explained by ectopic formation of tertiary lymphoid organs (TLOs), containing high endothelial venules (HEVs). We aimed to evaluate the presence of HEVs and TLOs in inflamed intestinal mucosa of newly diagnosed, untreated IBD patients in relation to the presence of TN and TCM lymphocytes. IBD patients (n = 39) and healthy controls (n = 8) were included prospectively. Biopsy samples of inflamed and normal intestine, respectively, were analysed by immunohistochemistry for lymphocytes (CD3/CD20), blood vessels (CD31) and peripheral lymph node addressin (PNAd) expression (MECA-79). TN and TCM lymphocyte subsets were identified by flow cytometric immunophenotyping. A higher number of HEVs was found in the inflamed colon of patients with ulcerative colitis [median 3·05 HEV/mm2 ; interquartile range (IQR) = 0-6·39] and ileum of Crohn's disease patients (1·40; 0-4·34) compared to healthy controls (both 0; P = 0·033). A high density of colonic HEVs (HEVhigh ) was associated with increased infiltration of TN and TCM in the inflamed gut (median 87%; IQR = 82-93% of T cell population), compared to HEVlow patients (58%; 38-81%; P = 0·003). The number of colonic follicles was higher in HEVhigh patients (median 0·54/mm2 ; IQR 0·28-0·84) compared to HEVlow patients (0·25/mm2 ; 0·08-0·45; P = 0·031) and controls (0·31/mm2 ; 0·23-0·45; P = 0·043). Increased homing of TN and TCM lymphocytes to inflamed gut tissue in IBD patients might be facilitated by ectopic formation of extrafollicular HEVs and TLOs in a subgroup of patients.
© 2016 British Society for Immunology.

Entities:  

Keywords:  T lymphocytes; high endothelial venules; inflammatory bowel disease; lymphocyte homing; tertiary lymphoid organ

Mesh:

Substances:

Year:  2017        PMID: 28033681      PMCID: PMC5343347          DOI: 10.1111/cei.12918

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Histopathology predictors of medically refractory ulcerative colitis.

Authors:  Joshua E Melson; Deborah Giusto; Mary Kwasny; Peter Eichenseer; Shriram Jakate; Ali Keshavarzian
Journal:  Dis Colon Rectum       Date:  2010-09       Impact factor: 4.585

2.  Evidence that a significant number of naive T cells enter non-lymphoid organs as part of a normal migratory pathway.

Authors:  Stephen Cose; Clair Brammer; Kamal M Khanna; David Masopust; Leo Lefrançois
Journal:  Eur J Immunol       Date:  2006-06       Impact factor: 5.532

Review 3.  Memory versus naive T-cell migration.

Authors:  Marie Lewis; John F Tarlton; Stephen Cose
Journal:  Immunol Cell Biol       Date:  2007-11-13       Impact factor: 5.126

4.  B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue.

Authors:  H S Carlsen; E S Baekkevold; F-E Johansen; G Haraldsen; P Brandtzaeg
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

5.  Vedolizumab as induction and maintenance therapy for ulcerative colitis.

Authors:  Brian G Feagan; Paul Rutgeerts; Bruce E Sands; Stephen Hanauer; Jean-Frédéric Colombel; William J Sandborn; Gert Van Assche; Jeffrey Axler; Hyo-Jong Kim; Silvio Danese; Irving Fox; Catherine Milch; Serap Sankoh; Tim Wyant; Jing Xu; Asit Parikh
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

Review 6.  Lymphoid neogenesis in chronic inflammatory diseases.

Authors:  Francesca Aloisi; Ricardo Pujol-Borrell
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

7.  Naive T cells in the gut of newly diagnosed, untreated adult patients with inflammatory bowel disease.

Authors:  Carmen S Horjus Talabur Horje; Sabine Middendorp; Elly van Koolwijk; Lian Roovers; Marcel J M Groenen; Peter J Wahab; Ellen G van Lochem
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

8.  Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets.

Authors:  Taheri Sathaliyawala; Masaru Kubota; Naomi Yudanin; Damian Turner; Philip Camp; Joseph J C Thome; Kara L Bickham; Harvey Lerner; Michael Goldstein; Megan Sykes; Tomoaki Kato; Donna L Farber
Journal:  Immunity       Date:  2012-12-20       Impact factor: 31.745

Review 9.  Ectopic lymphoid tissues and local immunity.

Authors:  Damian M Carragher; Javier Rangel-Moreno; Troy D Randall
Journal:  Semin Immunol       Date:  2008-02-19       Impact factor: 11.130

10.  TNFα-dependent development of lymphoid tissue in the absence of RORγt⁺ lymphoid tissue inducer cells.

Authors:  G C Furtado; M E Pacer; G Bongers; C Bénézech; Z He; L Chen; M C Berin; G Kollias; J H Caamaño; S A Lira
Journal:  Mucosal Immunol       Date:  2013-10-16       Impact factor: 7.313

View more
  9 in total

1.  Immune Profiling of Human Gut-Associated Lymphoid Tissue Identifies a Role for Isolated Lymphoid Follicles in Priming of Region-Specific Immunity.

Authors:  Thomas M Fenton; Peter B Jørgensen; Kristoffer Niss; Samuel J S Rubin; Urs M Mörbe; Lene B Riis; Clément Da Silva; Adam Plumb; Julien Vandamme; Henrik L Jakobsen; Søren Brunak; Aida Habtezion; Ole H Nielsen; Bengt Johansson-Lindbom; William W Agace
Journal:  Immunity       Date:  2020-03-10       Impact factor: 31.745

Review 2.  Human gut-associated lymphoid tissues (GALT); diversity, structure, and function.

Authors:  Urs M Mörbe; Peter B Jørgensen; Thomas M Fenton; Nicole von Burg; Lene B Riis; Jo Spencer; William W Agace
Journal:  Mucosal Immunol       Date:  2021-03-22       Impact factor: 7.313

Review 3.  Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy.

Authors:  Liangbin Lin; Xiang Hu; Huiyuan Zhang; Hongbo Hu
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

4.  Enriched CD45RA-CD62L+ central memory T and decreased CD3+CD56+ natural killer T lymphocyte subsets in the rectum of ulcerative colitis patients.

Authors:  Masaya Iwamuro; Takahide Takahashi; Natsuki Watanabe; Takehiro Tanaka; Toshihiro Inokuchi; Sakiko Hiraoka; Fumio Otsuka; Hiroyuki Okada
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

Review 5.  The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease.

Authors:  Dimitrios Nikolakis; Floris A E de Voogd; Maarten J Pruijt; Joep Grootjans; Marleen G van de Sande; Geert R D'Haens
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

Review 6.  Colitis and Colorectal Carcinogenesis: The Focus on Isolated Lymphoid Follicles.

Authors:  Györgyi Műzes; Bettina Bohusné Barta; Ferenc Sipos
Journal:  Biomedicines       Date:  2022-01-21

7.  Development of Mucosal PNAd+ and MAdCAM-1+ Venules during Disease Course in Ulcerative Colitis.

Authors:  Britt Roosenboom; Ellen G van Lochem; Jos Meijer; Carolijn Smids; Stefan Nierkens; Eelco C Brand; Liselot W van Erp; Larissa G J M Kemperman; Marcel J M Groenen; Carmen S Horjus Talabur Horje; Peter J Wahab
Journal:  Cells       Date:  2020-04-06       Impact factor: 6.600

8.  Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial.

Authors:  Nikhil Pai; Jelena Popov; Lee Hill; Emily Hartung
Journal:  BMJ Open       Date:  2019-11-28       Impact factor: 2.692

Review 9.  High endothelial venules (HEVs) in immunity, inflammation and cancer.

Authors:  Lucas Blanchard; Jean-Philippe Girard
Journal:  Angiogenesis       Date:  2021-05-06       Impact factor: 9.596

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.